Stéphane Bancel, Moderna CEO (Lenin Nolly/NurPhoto via AP Images)
May 28, 2025 06:01 PM EDTUpdated 06:58 PM
Pharma
Coronavirus

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

Max Bayer

Pharma Reporter

The Trump ad­min­is­tra­tion has killed an award worth $766 mil­lion to help Mod­er­na de­vel­op a bird flu vac­cine, ac­cord­ing to the com­pa­ny.

The biotech said …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

Supreme Court to keep mulling state PBM dis­pute as US urges jus­tices to de­cline case

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

DNA gi­ant Il­lu­mi­na spawned an ecosys­tem of com­peti­tors and cus­tomers

FDA re­jects Stealth's rare dis­ease drug, but of­fers po­ten­tial for ac­cel­er­at­ed ap­proval

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times